These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8131440)
1. Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function. Santinelli V; Arnese M; Oppo I; Matarazzi C; Maione S; Palma M; Giunta A Chest; 1993 Apr; 103(4):1068-73. PubMed ID: 8131440 [TBL] [Abstract][Full Text] [Related]
2. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. Chimienti M; Cullen MT; Casadei G Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031 [TBL] [Abstract][Full Text] [Related]
3. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy]. Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831 [TBL] [Abstract][Full Text] [Related]
4. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?]. Inama G; Furlanello F; Braito G; Guarnerio M; Vergara G G Ital Cardiol; 1991 Feb; 21(2):131-8. PubMed ID: 1907937 [TBL] [Abstract][Full Text] [Related]
5. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814 [TBL] [Abstract][Full Text] [Related]
6. Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs. Sakanashi M; Noguchi K; Matsuzaki T; Ojiri Y; Nakasone J; Itomine T; Higuchi M; Shiroma N Cardioscience; 1993 Dec; 4(4):241-50. PubMed ID: 8298065 [TBL] [Abstract][Full Text] [Related]
7. Long term inotropic effects of flecainide and propafenone. Henze E; Roth J; Haerer W; Adam WE; Stauch M Eur J Nucl Med; 1988; 13(11):568-71. PubMed ID: 2450751 [TBL] [Abstract][Full Text] [Related]
8. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329 [TBL] [Abstract][Full Text] [Related]
9. Effects of flecainide on exercise hemodynamics and electrocardiography in patients without structural heart disease. Wang JA; Lau CP; Tai YT; Wu BZ Clin Cardiol; 1995 Mar; 18(3):140-4. PubMed ID: 7743684 [TBL] [Abstract][Full Text] [Related]
10. Comparative hemodynamic effects of Org 7797, flecainide, and propafenone in anesthetized pigs with developing myocardial infarcts. Winslow E; Mason R J Cardiovasc Pharmacol; 1992 Mar; 19(3):435-41. PubMed ID: 1378126 [TBL] [Abstract][Full Text] [Related]
11. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency. Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020 [TBL] [Abstract][Full Text] [Related]
12. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054 [TBL] [Abstract][Full Text] [Related]
13. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs. Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Biffi M; Boriani G; Bronzetti G; Capucci A; Branzi A; Magnani B Heart; 1999 Aug; 82(2):176-82. PubMed ID: 10409531 [TBL] [Abstract][Full Text] [Related]
15. Class IC drugs: propafenone and flecainide. Puech P; Gagnol JP Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():549-53. PubMed ID: 2125832 [TBL] [Abstract][Full Text] [Related]
16. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.). Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837 [TBL] [Abstract][Full Text] [Related]
17. Translational assessment of cardiac contractility by echocardiography in the telemetered rat. Tang HM; Ju H; Zhao S; LaDuke C; Hahn S; Glick J; Carey C; Friedrichs GS J Pharmacol Toxicol Methods; 2016; 77():24-32. PubMed ID: 26427954 [TBL] [Abstract][Full Text] [Related]
18. Echocardiography, a non-invasive method for the investigation of heart morphology and function in laboratory dogs: 2. Effects of minoxidil and quinidine on the left ventricle function. Hanton G; Lodola A Lab Anim; 1998 Apr; 32(2):183-90. PubMed ID: 9587901 [TBL] [Abstract][Full Text] [Related]
19. Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram. Lombardi F; Finocchiaro ML; Dalla Vecchia L; Rech R; Castelli A; Pastine J; Cappiello E Eur Heart J; 1992 Apr; 13(4):517-25. PubMed ID: 1600992 [TBL] [Abstract][Full Text] [Related]
20. The clinical use of class IC antiarrhythmic drugs. Abi Samra F J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]